Reduced glutathione level in the aqueous humor of patients with primary open-angle glaucoma and normal-tension glaucoma.


Journal

npj aging
ISSN: 2731-6068
Titre abrégé: NPJ Aging
Pays: England
ID NLM: 9918402285106676

Informations de publication

Date de publication:
21 Nov 2023
Historique:
received: 10 02 2023
accepted: 22 09 2023
medline: 22 11 2023
pubmed: 22 11 2023
entrez: 22 11 2023
Statut: epublish

Résumé

Glaucoma is a leading cause of blindness worldwide in older people. Profiling the aqueous humor, including the metabolites it contains, is useful to understand physiological and pathological conditions in the eye. In the current study, we used mass spectrometry (MS) to characterize the aqueous humor metabolomic profile and biological features of patients with glaucoma. Aqueous humor samples were collected during trabeculectomy surgery or cataract surgery and analyzed with global metabolomics. We included 40 patients with glaucoma (32 with POAG, 8 with NTG) and 37 control subjects in a discovery study. VIP analysis revealed five metabolites that were elevated and three metabolites that were reduced in the glaucoma patients. The identified metabolomic profile had an area under the receiver operating characteristic curve of 0.953. Among eight selected metabolites, the glutathione level was significantly decreased in association with visual field defects. Moreover, in a validation study to confirm the reproducibility of our findings, the glutathione level was reduced in NTG and POAG patients compared with a cataract control group. Our findings demonstrate that aqueous humor profiling can help to diagnose glaucoma and that various aqueous humor metabolites are correlated with clinical parameters in glaucoma patients. In addition, glutathione is clearly reduced in the aqueous humor of glaucoma patients with both IOP-dependent and IOP-independent disease subtypes. These findings indicate that antioxidant agents in the aqueous humor reflect glaucomatous optic nerve damage and that excessive oxidative stress may be involved in the pathogenesis of glaucoma.

Identifiants

pubmed: 37990002
doi: 10.1038/s41514-023-00124-2
pii: 10.1038/s41514-023-00124-2
pmc: PMC10663551
doi:

Types de publication

Journal Article

Langues

eng

Pagination

28

Informations de copyright

© 2023. The Author(s).

Références

BMC Ophthalmol. 2020 May 6;20(1):183
pubmed: 32375707
J Clin Med. 2021 Mar 12;10(6):
pubmed: 33808966
Hum Mol Genet. 2018 Apr 15;27(8):1486-1496
pubmed: 29452408
Neurobiol Aging. 2018 Nov;71:223-233
pubmed: 30172221
Exp Eye Res. 2012 Oct;103:55-62
pubmed: 22974818
Cell Death Dis. 2017 Apr 20;8(4):e2752
pubmed: 28425986
J Proteome Res. 2019 Mar 1;18(3):1307-1315
pubmed: 30701980
PLoS One. 2019 Dec 30;14(12):e0227078
pubmed: 31887133
Arch Ophthalmol. 1979 Mar;97(3):525-31
pubmed: 84662
J Neurochem. 2013 Dec;127(5):669-80
pubmed: 23721546
Nat Commun. 2021 Feb 24;12(1):1258
pubmed: 33627673
Proc Natl Acad Sci U S A. 2020 Dec 29;117(52):33619-33627
pubmed: 33318177
Aging Cell. 2020 Feb;19(2):e13089
pubmed: 31867890
BMC Res Notes. 2015 Aug 19;8:360
pubmed: 26286038
Exp Eye Res. 2020 May;194:108024
pubmed: 32246983
Lancet. 2017 Nov 11;390(10108):2183-2193
pubmed: 28577860
Exp Eye Res. 2020 Dec;201:108268
pubmed: 33011236
PLoS One. 2016 Aug 31;11(8):e0160555
pubmed: 27579980
Invest Ophthalmol Vis Sci. 2019 Oct 1;60(13):4479-4488
pubmed: 31661548
Ophthalmology. 2004 Sep;111(9):1641-8
pubmed: 15350316
PLoS One. 2020 Jan 16;15(1):e0227887
pubmed: 31945125
J Proteome Res. 2010 Sep 3;9(9):4831-8
pubmed: 20666514
Curr Eye Res. 2016 Nov;41(11):1447-1453
pubmed: 27159148
Mol Cell. 2015 Sep 17;59(6):931-40
pubmed: 26365380
Redox Biol. 2021 May;41:101921
pubmed: 33706170
Invest Ophthalmol Vis Sci. 2002 Nov;43(11):3465-72
pubmed: 12407157
Science. 2023 Jun 9;380(6649):eabn9257
pubmed: 37289866
Mol Omics. 2020 Oct 12;16(5):425-435
pubmed: 32149291
Oxid Med Cell Longev. 2017;2017:9208489
pubmed: 28194256
Biochem Biophys Res Commun. 2020 Jul 5;527(4):1064-1071
pubmed: 32448504
J Proteome Res. 2018 Jul 6;17(7):2499-2510
pubmed: 29901396
Biol Chem. 1997 Aug;378(8):793-802
pubmed: 9377474
Arch Ophthalmol. 2011 Dec;129(12):1630-1
pubmed: 22159688
Am J Ophthalmol. 2004 Jan;137(1):62-9
pubmed: 14700645
Science. 1996 Jul 5;273(5271):59-63
pubmed: 8658196
Sci Rep. 2018 Aug 9;8(1):11930
pubmed: 30093719
Metabolites. 2021 Jan 14;11(1):
pubmed: 33466750
J Neurochem. 2007 Feb;100(4):1018-31
pubmed: 17266736
Sci Rep. 2019 Oct 30;9(1):15636
pubmed: 31666674

Auteurs

Kota Sato (K)

Department of Ophthalmology, Tohoku University Graduate School of Medicine, Sendai, Miyagi, Japan.
Department of Ophthalmic Imaging and Information Analytics, Tohoku University Graduate School of Medicine, Sendai, Miyagi, Japan.

Daisuke Saigusa (D)

Laboratory of Biomedical and Analytical Sciences, Faculty of Pharma-Science, Teikyo University, Tokyo, Japan.
Department of Integrative Genomics, Tohoku Medical Megabank Organization, Tohoku University, Sendai, Miyagi, Japan.
Medical Biochemistry, Tohoku University School of Medicine, Sendai, Miyagi, Japan.

Taiki Kokubun (T)

Department of Ophthalmology, Tohoku University Graduate School of Medicine, Sendai, Miyagi, Japan.

Amane Fujioka (A)

Department of Ophthalmology, Tohoku University Graduate School of Medicine, Sendai, Miyagi, Japan.

Qiwei Feng (Q)

Department of Ophthalmology, Tohoku University Graduate School of Medicine, Sendai, Miyagi, Japan.

Ritsumi Saito (R)

Department of Integrative Genomics, Tohoku Medical Megabank Organization, Tohoku University, Sendai, Miyagi, Japan.
Medical Biochemistry, Tohoku University School of Medicine, Sendai, Miyagi, Japan.

Akira Uruno (A)

Department of Integrative Genomics, Tohoku Medical Megabank Organization, Tohoku University, Sendai, Miyagi, Japan.
Medical Biochemistry, Tohoku University School of Medicine, Sendai, Miyagi, Japan.

Naomi Matsukawa (N)

Department of Integrative Genomics, Tohoku Medical Megabank Organization, Tohoku University, Sendai, Miyagi, Japan.

Michiko Ohno-Oishi (M)

Department of Ophthalmology, Tohoku University Graduate School of Medicine, Sendai, Miyagi, Japan.

Hiroshi Kunikata (H)

Department of Ophthalmology, Tohoku University Graduate School of Medicine, Sendai, Miyagi, Japan.

Yu Yokoyama (Y)

Department of Ophthalmology, Tohoku University Graduate School of Medicine, Sendai, Miyagi, Japan.

Masayuki Yasuda (M)

Department of Ophthalmology, Tohoku University Graduate School of Medicine, Sendai, Miyagi, Japan.

Noriko Himori (N)

Department of Ophthalmology, Tohoku University Graduate School of Medicine, Sendai, Miyagi, Japan.
Department of Aging Vision Healthcare, Tohoku University Graduate School of Medicine, Sendai, Miyagi, Japan.

Kazuko Omodaka (K)

Department of Ophthalmology, Tohoku University Graduate School of Medicine, Sendai, Miyagi, Japan.

Satoru Tsuda (S)

Department of Ophthalmology, Tohoku University Graduate School of Medicine, Sendai, Miyagi, Japan.

Shigeto Maekawa (S)

Department of Ophthalmology, Tohoku University Graduate School of Medicine, Sendai, Miyagi, Japan.

Masayuki Yamamoto (M)

Department of Integrative Genomics, Tohoku Medical Megabank Organization, Tohoku University, Sendai, Miyagi, Japan.
Medical Biochemistry, Tohoku University School of Medicine, Sendai, Miyagi, Japan.

Toru Nakazawa (T)

Department of Ophthalmology, Tohoku University Graduate School of Medicine, Sendai, Miyagi, Japan. ntoru@oph.med.tohoku.ac.jp.
Department of Ophthalmic Imaging and Information Analytics, Tohoku University Graduate School of Medicine, Sendai, Miyagi, Japan. ntoru@oph.med.tohoku.ac.jp.
Department of Retinal Disease Control, Tohoku University Graduate School of Medicine, Sendai, Miyagi, Japan. ntoru@oph.med.tohoku.ac.jp.
Department of Advanced Ophthalmic Medicine, Tohoku University Graduate School of Medicine, Sendai, Miyagi, Japan. ntoru@oph.med.tohoku.ac.jp.
Department of Collaborative Program for Ophthalmic Drug Discovery, Tohoku University Graduate School of Medicine, Sendai, Miyagi, Japan. ntoru@oph.med.tohoku.ac.jp.

Classifications MeSH